HRI received $100,000 from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations.HRI’s Director of Evaluation, Dr. Jean Costello, led the study, which utilized patient data from Homewood Health Centre and St. Joseph’s Healthcare Hamilton. The study was co-led by HRI Senior […]
Read More
Last year, HRI received $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations. Findings from this project are now available.
Read More
HRI is proud to partner with the Canadian Centre on Substance Use and Addiction (CCSA). Together, we’re closing knowledge gaps and advancing knowledge about substance use and addiction in Canada.
Read More
We are proud to welcome Marie Gendy, MD, MSc and PhD, to HRI as a Post-Doctoral Fellow. Dr. Gendy joins us through the Mitacs Accelerate Industrial Fellowship program. Her work explores diverse characteristics among people with addiction-related illness to help identify targeted treatment approaches that better match individual needs.
Read More
Congratulations to Emily Levitt, who is this year’s recipient of the Darlene Walton Scholarship Award! This award recognizes students who demonstrate excellence in mental health and addiction research, doing work that enhances practice.
Read More
HRI has released a new infographic featuring recent findings from a study shedding light on the process of recovery from mental illness and addiction.
Read More
HRI is the proud recipient of $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations, including people requiring treatment for mental illness and substance use disorder (SUD).
Read More
In our latest Research Snapshot, we profile findings about improvements to screening tools that may help to identify concurrent mental health conditions in people requiring treatment for addiction.
Read More
HRI Senior Scientist, Dr. James MacKillop, has received $491,000 from the Canadian Institutes of Health Research (CIHR) for a study that will examine the impact of COVID-19 on mental health and substance use.
Read MoreTreatment of alcohol use disorder is multi-faceted and often includes participation in mutual-support groups, the oldest and largest of which is Alcoholics Anonymous (AA). Although frequent AA meeting attendance is associated with greater abstinence from alcohol, there is little understanding of the specific mechanisms by which AA benefits people. In other words, we know that AA works, […]
Read More